Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Pharmaceutical Statistics|September 14, 2007
The impact of missing data and how it is handled on the rate of false-positive results in drug developmentSunni A Barnes, Craig H Mallinckrodt, Stacy R Lindborg, et al.
Journal of Biopharmaceutical Statistics|May 6, 2003
Assessing response profiles from incomplete longitudinal clinical trial data under regulatory considerationsCraig H Mallinckrodt, S W Scott Clark, Raymond J Carroll, et al.
BMC Geriatrics|December 9, 2004
Duloxetine for the long-term treatment of major depressive disorder in patients aged 65 and older: an open-label studyMadelaine M Wohlreich, Craig H Mallinckrodt, John G Watkin, et al.
Pharmaceutical Statistics|July 28, 2018
Points to consider for analyzing efficacy outcomes in long-term extension clinical trialsBohdana Ratitch, Ilya Lipkovich, Janelle Shannon Erickson, et al.
BMC Psychiatry|January 6, 2005
Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic featuresCraig H Mallinckrodt, John G Watkin, Chaofeng Liu, et al.
Clinical Therapeutics|November 9, 2004
Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetineJohn Greist, Robert K McNamara, Craig H Mallinckrodt, et al.
Clinical Trials (London, England)|November 11, 2005
The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVACraig H Mallinckrodt, Christopher J Kaiser, John G Watkin, et al.
Psychopharmacology Bulletin|May 22, 2007
Simple options for improving signal detection in antidepressant clinical trialsCraig H Mallinckrodt, Adam L Meyers, Apurva Prakash, et al.
The Journal of Clinical Psychiatry|May 4, 2004
The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?Maurizio Fava, Craig H Mallinckrodt, Michael J Detke, et al.
Pharmaceutical Statistics|April 14, 2015
To adjust or not to adjust for baseline when analyzing repeated binary responses? The case of complete data when treatment comparison at study end is of interestHonghua Jiang, Pandurang M Kulkarni, Craig H Mallinckrodt, et al.
Pageof 6